2002
DOI: 10.1016/s0003-9861(02)00527-1
|View full text |Cite
|
Sign up to set email alerts
|

Purification and characterization of a glycoprotein inhibitor of toxic phospholipase from Withania somnifera

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
19
0
1

Year Published

2005
2005
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 38 publications
(22 citation statements)
references
References 55 publications
2
19
0
1
Order By: Relevance
“…Injection of group IIA sPLA 2 from human synovial fluid and snake venom (group IA, group IIA and IIB) into animal joints confirms the development of acute inflammatory response [24][25][26]. Demonstration of sPLA 2 inhibitors as suppressor of inflammatory process provides a strong evidence for their role in inflammation [27,28]. However, other human sPLA 2 s are currently under intensive research regarding their involvement in various biological functions and their role in diseased conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Injection of group IIA sPLA 2 from human synovial fluid and snake venom (group IA, group IIA and IIB) into animal joints confirms the development of acute inflammatory response [24][25][26]. Demonstration of sPLA 2 inhibitors as suppressor of inflammatory process provides a strong evidence for their role in inflammation [27,28]. However, other human sPLA 2 s are currently under intensive research regarding their involvement in various biological functions and their role in diseased conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Injection of inflammatory HSF PLA 2 (group IIA) and snake venom PLA 2 (group IA, group IIA and IIB) into animal joints confirms the development of acute inflammatory responses. Demonstration of sPLA 2 inhibitors as suppressor of inflammatory process provides a strong evidence for their role in inflammation (Jameel et al, 2005;Teixeira et al, 2003;Bomalaski et al, 1991;Weichman et al, 1989;Deepa and Gowda, 2002;Vishwanath et al, 1988). However, other human sPLA 2 s are under intensive research regarding their involvement in various biological functions and in diseases.…”
Section: Discussionmentioning
confidence: 99%
“…These are inhibited by the aqueous leaf extract of Witlania somnifera. It is due to the glycoprotein as responsible for this activity 23 .…”
Section: Resultsmentioning
confidence: 99%